Hagan Barron Intermediaries

Hagan Barron Intermediaries (HBI) is a boutique strategic advisory firm dedicated to the life sciences, biotechnology, and pharmaceutical sectors. The firm specializes in business development, providing services such as asset out-licensing, technology in-licensing, and strategic partnership identification. HBI supports its clients through the entire deal-making process, including valuation, due diligence management, and contract negotiation. By leveraging extensive industry experience and a global network, the company helps emerging biotechs and established pharma companies optimize their portfolios and execute corporate growth strategies. The firm is particularly active in facilitating transactions for early-to-mid-stage therapeutic assets across various therapeutic areas.